SE463069B - Foerfarande foer framstaellning av livsmedel eller djurfoder innehaallande ett antibakteriellt system, daervid framstaellda produkter samt det antibakteriella systemet innefattande laktoperoxidas och laktoferrin - Google Patents

Foerfarande foer framstaellning av livsmedel eller djurfoder innehaallande ett antibakteriellt system, daervid framstaellda produkter samt det antibakteriella systemet innefattande laktoperoxidas och laktoferrin

Info

Publication number: SE463069B
Authority: SE; Sweden
Prior art keywords: lactoperoxidase; lactoferrin; per liter; amount; milk substitute
Prior art date: 1984-07-25

Application number

SE8503570A

Other languages

English (en)

Swedish (sv)

Other versions

SE8503570L (sv

SE8503570D0 (sv

Inventor

J-P H P Prieels

J-P Perraudin

Original Assignee

Oleofina Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-07-25

Filing date

1985-07-23

Publication date

1990-10-08

1985-07-23 Application filed by Oleofina Sa filed Critical Oleofina Sa

1985-07-23 Publication of SE8503570D0 publication Critical patent/SE8503570D0/xx

1986-01-26 Publication of SE8503570L publication Critical patent/SE8503570L/xx

1990-10-08 Publication of SE463069B publication Critical patent/SE463069B/sv

Links

230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 26
238000000034 method Methods 0.000 title claims abstract description 10
241001465754 Metazoa Species 0.000 title claims abstract description 7
238000002360 preparation method Methods 0.000 title claims description 6
235000013305 food Nutrition 0.000 title claims 7
239000000203 mixture Substances 0.000 claims abstract description 52
229940057428 lactoperoxidase Drugs 0.000 claims abstract description 34
108010023244 Lactoperoxidase Proteins 0.000 claims abstract description 32
102000045576 Lactoperoxidases Human genes 0.000 claims abstract description 32
229940078795 lactoferrin Drugs 0.000 claims abstract description 29
102000010445 Lactoferrin Human genes 0.000 claims abstract description 28
108010063045 Lactoferrin Proteins 0.000 claims abstract description 28
CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 28
235000021242 lactoferrin Nutrition 0.000 claims abstract description 28
210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 13
235000013384 milk substitute Nutrition 0.000 claims description 19
239000002243 precursor Substances 0.000 claims description 19
ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims description 14
ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims description 14
239000004366 Glucose oxidase Substances 0.000 claims description 6
229940116332 glucose oxidase Drugs 0.000 claims description 6
XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 claims description 4
239000012190 activator Substances 0.000 claims description 3
229910052802 copper Inorganic materials 0.000 claims description 3
239000010949 copper Substances 0.000 claims description 3
235000016709 nutrition Nutrition 0.000 claims description 3
108010015776 Glucose oxidase Proteins 0.000 claims description 2
235000019420 glucose oxidase Nutrition 0.000 claims description 2
239000003513 alkali Substances 0.000 claims 2
229910052783 alkali metal Inorganic materials 0.000 claims 2
150000001340 alkali metals Chemical class 0.000 claims 2
239000004202 carbamide Substances 0.000 claims 1
AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims 1
-1 urea peroxides Chemical class 0.000 claims 1
241000124008 Mammalia Species 0.000 abstract 4
206010017964 Gastrointestinal infection Diseases 0.000 abstract 2
230000003213 activating effect Effects 0.000 abstract 1
244000309466 calf Species 0.000 description 8
206010012735 Diarrhoea Diseases 0.000 description 4
230000000694 effects Effects 0.000 description 4
239000004615 ingredient Substances 0.000 description 4
230000000968 intestinal effect Effects 0.000 description 4
230000004584 weight gain Effects 0.000 description 4
235000019786 weight gain Nutrition 0.000 description 4
230000000052 comparative effect Effects 0.000 description 3
235000013336 milk Nutrition 0.000 description 3
239000008267 milk Substances 0.000 description 3
210000004080 milk Anatomy 0.000 description 3
239000000825 pharmaceutical preparation Substances 0.000 description 3
239000000843 powder Substances 0.000 description 3
VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 3
230000002195 synergetic effect Effects 0.000 description 3
208000035143 Bacterial infection Diseases 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
241001494479 Pecora Species 0.000 description 2
241000282887 Suidae Species 0.000 description 2
239000013543 active substance Substances 0.000 description 2
208000022362 bacterial infectious disease Diseases 0.000 description 2
230000037396 body weight Effects 0.000 description 2
239000003937 drug carrier Substances 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
235000012041 food component Nutrition 0.000 description 2
239000008101 lactose Substances 0.000 description 2
239000000243 solution Substances 0.000 description 2
QKEYIYSLARKMSJ-UHFFFAOYSA-N 1-benzyl-3-(dimethylamino)-2,2-dimethyl-3,4-dihydronaphthalene-1,7-diol;hydrobromide Chemical compound Br.CC1(C)C(N(C)C)CC2=CC=C(O)C=C2C1(O)CC1=CC=CC=C1 QKEYIYSLARKMSJ-UHFFFAOYSA-N 0.000 description 1
239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
235000019743 Choline chloride Nutrition 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
239000005662 Paraffin oil Substances 0.000 description 1
241000588769 Proteus <enterobacteria> Species 0.000 description 1
241000700159 Rattus Species 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
241000607768 Shigella Species 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
230000001142 anti-diarrhea Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
229960003178 choline chloride Drugs 0.000 description 1
SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
150000002978 peroxides Chemical class 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
229940045872 sodium percarbonate Drugs 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000011343 solid material Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Mycology (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Fodder In General (AREA)
Feed For Specific Animals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
General Preparation And Processing Of Foods (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

SE8503570A 1984-07-25 1985-07-23 Foerfarande foer framstaellning av livsmedel eller djurfoder innehaallande ett antibakteriellt system, daervid framstaellda produkter samt det antibakteriella systemet innefattande laktoperoxidas och laktoferrin SE463069B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
LU85479A LU85479A1 (fr)	1984-07-25	1984-07-25	Compositions antibacteriennes de nourriture pour animaux et procede pour les preparer

Publications (3)

Publication Number	Publication Date
SE8503570D0 SE8503570D0 (sv)	1985-07-23
SE8503570L SE8503570L (sv)	1986-01-26
SE463069B true SE463069B (sv)	1990-10-08

Family

ID=19730296

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8503570A SE463069B (sv)	1984-07-25	1985-07-23	Foerfarande foer framstaellning av livsmedel eller djurfoder innehaallande ett antibakteriellt system, daervid framstaellda produkter samt det antibakteriella systemet innefattande laktoperoxidas och laktoferrin

Country Status (19)

Country	Link
US (1)	US4726948A (da)
JP (1)	JPS6183131A (da)
AU (1)	AU582769B2 (da)
BE (1)	BE902943A (da)
CA (1)	CA1260390A (da)
CH (1)	CH667775A5 (da)
DE (1)	DE3525902C2 (da)
DK (1)	DK163951C (da)
FI (1)	FI86133C (da)
FR (1)	FR2573982B1 (da)
GB (1)	GB2162063B (da)
IE (1)	IE58733B1 (da)
IT (1)	IT1187697B (da)
LU (1)	LU85479A1 (da)
NL (1)	NL8502110A (da)
NO (1)	NO165473C (da)
NZ (1)	NZ212869A (da)
PT (1)	PT80861B (da)
SE (1)	SE463069B (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2600250B1 (fr) *	1986-06-23	1989-11-24	Bio Serae	Procede pour conditionner une composition antibacterienne et composition antibacterienne conditionnee
SE8701839L (sv) *	1987-05-05	1988-11-06	Ewos Ab	Livs- och fodermedel
US5344820A (en) *	1987-05-15	1994-09-06	Snow Brand Milk Products Co., Ltd.	Infection protectant
US4977137B1 (en) *	1987-06-03	1994-06-28	Baylor College Medicine	Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US4987124A (en) *	1987-10-13	1991-01-22	Coors Biotech, Inc.	Method for inhibiting the growth of salmonella
US5032579A (en) *	1987-10-13	1991-07-16	Coors Biotech, Inc.	Method for inhibiting the growth of salmonella
US4902674A (en) *	1987-10-13	1990-02-20	Coors Biotech, Inc.	Method for inhibiting the growth of salmonella
JP2805490B2 (ja) *	1989-02-07	1998-09-30	雪印乳業株式会社	細菌毒素中和剤
US6100054A (en) *	1989-05-05	2000-08-08	Baylor College Of Medicine	Production for recombinant lactoferrin and lactoferrin polypeptides using DNA sequences in various organisms
IL94183A (en)	1989-05-05	2003-09-17	Baylor College Medicine	cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE
US5766939A (en) *	1989-05-05	1998-06-16	Baylor College Of Medicine	Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
US5849881A (en) *	1989-05-05	1998-12-15	Baylor College Medicine	Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
US5571691A (en) *	1989-05-05	1996-11-05	Baylor College Of Medicine	Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
FR2648321B1 (fr) *	1989-05-12	1992-01-17	Bio Serae Lab	Procede de traitement d'un produit alimentaire non liquide pour assurer sa decontamination microbienne, applications en particulier aux fromages et preparation mere pour la mise en oeuvre dudit traitement
US5008120A (en) *	1989-07-21	1991-04-16	Snow Brand Milk Products Co., Ltd.	Method of preparing iron-fortified beverage
US5756333A (en) *	1989-11-03	1998-05-26	Incyte Pharmaceuticals, Inc.	Recombinant production of lactoperoxidase
ATE193324T1 (de) *	1989-11-03	2000-06-15	Incyte Pharma Inc	Rekombinante herstellung von laktoperoxidase
US5633076A (en) *	1989-12-01	1997-05-27	Pharming Bv	Method of producing a transgenic bovine or transgenic bovine embryo
JPH03181421A (ja) *	1989-12-08	1991-08-07	Chugai Pharmaceut Co Ltd	ベータラクタム系抗生物質の作用増強剤並びに感染症予防及び治療用の医薬組成物
US5198419A (en) *	1989-12-08	1993-03-30	Immuno Japan Inc.	Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria
GB9002422D0 (en) *	1990-02-03	1990-04-04	Boots Co Plc	Anti-microbial compositions
US5240909B1 (en) *	1990-03-14	1998-01-20	Dietrich Nitsche	Use of lactoferrin for treatment of toxic effects of endotoxins
JP2808166B2 (ja) *	1990-04-26	1998-10-08	雪印乳業株式会社	鉄強化飲料の製造方法
JP2840795B2 (ja) *	1990-11-13	1998-12-24	参天製薬株式会社	角膜障害治療剤
US5565197A (en) *	1991-02-21	1996-10-15	Exoxemis, Inc.	Method which utilizes a haloperoxidase composition to inhibit the growth of microorganisms which cause sexually transmitted diseases
US5756090A (en) *	1991-02-21	1998-05-26	Eoe, Inc.	Oxygen activatable formulations for disinfection or sterilization
US5888505A (en) *	1991-02-21	1999-03-30	Eoe, Inc.	Method for selectively inhibiting the growth of microbes using a haloperoxidase-halide-peroxide system
AU663869B2 (en) *	1991-02-21	1995-10-26	Exoxemis, Inc.	Methods and compositions for the treatment of infection and control of flora
US5292523A (en) *	1991-12-11	1994-03-08	Nippon Kayaku Kabushiki Kaisha	Method for growth promotion of animals and powder compositions containing killed microbial cells of bacteria belonging to genus clostridium
FR2685202B1 (fr) *	1991-12-24	1995-03-24	Sederma Sa	Nouvelle methode de traitement pharmaceutique et cosmetique pour la regulation de la seborrhee, de l'acne et de la flore cutanee.
US6111081A (en) *	1996-05-31	2000-08-29	Baylor College Of Medicine	Lactoferrin variants and uses thereof
US6342528B1 (en) *	2000-01-18	2002-01-29	Lynntech, Inc.	Control of microbial populations in the gastrointestinal tract of animals
WO2003009702A1 (en) *	2001-07-20	2003-02-06	Dsm Ip Assets B.V.	Animal feed with antimicrobial reactive oxygen species
WO2003047363A1 (en) *	2001-12-05	2003-06-12	Dsm Ip Assets B.V.	Methods and compositions for use in pet breeding
CA2489208C (en)	2003-02-24	2012-11-06	Morinaga Milk Industry Co., Ltd.	Interleukin-6 suppressive agent
CN1774324A (zh) *	2003-04-15	2006-05-17	帝斯曼知识产权资产管理有限公司	饲料添加剂组合物
JP4536341B2 (ja) *	2003-08-15	2010-09-01	雪印乳業株式会社	骨形成促進剤
US8647619B2 (en) *	2003-08-15	2014-02-11	Megmilk Snow Brand Co., Ltd.	Osteogenesis promoter
US20060289354A1 (en) *	2005-06-15	2006-12-28	Buckman Laboratories International, Inc.	Method and composition to control the growth of microorganisms in aqueous systems and on substrates
US8945540B2 (en) *	2008-05-09	2015-02-03	Exoxemis, Inc.	Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
WO2010071222A1 (ja) *	2008-12-20	2010-06-24	味の素株式会社	反芻動物用メタン生成抑制剤および飼料組成物
WO2011056477A2 (en) *	2009-10-26	2011-05-12	Zhe Lu	Methods for treating inflammation and oxidative stress related diseases
US8865770B2 (en) *	2011-01-06	2014-10-21	Vets Plus, Inc.	Carbamide peroxide treatments for the reproductive tract
EP2510944A1 (en)	2011-04-15	2012-10-17	National University of Ireland, Galway	Treatment of bacterial infections
WO2013009910A2 (en)	2011-07-11	2013-01-17	Exoxemis, Inc.	Eosinophil peroxidase compositions and methods of their use
PL2594282T3 (pl) *	2011-11-21	2015-01-30	Nestec Sa	Laktoferyna i istota biała
ES2665420T3 (es)	2013-05-08	2018-04-25	Novozymes A/S	Enzimas de pienso para animales
GB2540130B (en) *	2015-06-29	2021-04-14	Institute Of Tech Sligo	A composition and a method for controlling bacterial infection
EP3445387A4 (en) *	2016-04-21	2019-12-11	Quantec Limited	COMBINATION, THERAPEUTIC USES AND PROPHYLACTIC USES
JP7281729B2 (ja) *	2019-01-30	2023-05-26	学校法人帝京大学	抗真菌用組成物
GB2609445A (en) *	2021-07-30	2023-02-08	Glasport Bio Ltd	Compositions and methods
WO2023153945A1 (en) *	2022-02-14	2023-08-17	Quantec Limited	Combination, therapeutic uses and prophylactic uses
GB2635741B (en) *	2023-11-24	2026-03-18	Killian Obriain	Composition and use thereof for the treatment of equine gastric ulcer syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE420793B (sv) *	1976-03-08	1981-11-02	Astra Ewos Ab	Fodermedel innehallande ett antibakteriellt system
US4402938A (en) *	1980-05-29	1983-09-06	Impro Products, Inc.	Food and the method of extracting the same from colostrum and milk
US4477432A (en) *	1981-05-01	1984-10-16	Cutter Laboratories, Inc.	Oral immune globulin
JPS592686A (ja) *	1982-06-25	1984-01-09	Green Cross Corp:The	ミエロペルオキシダ−ゼの粉末製剤
JPS59231011A (ja) *	1983-06-06	1984-12-25	ラクレ−デ・プロフエツシヨナル・プロダクツ・インコ−ポレ−テツド	二酵素糸歯みがき

1984
- 1984-07-25 LU LU85479A patent/LU85479A1/fr unknown
1985
- 1985-07-18 AU AU45155/85A patent/AU582769B2/en not_active Ceased
- 1985-07-19 BE BE0/215385A patent/BE902943A/fr not_active IP Right Cessation
- 1985-07-19 IT IT21651/85A patent/IT1187697B/it active
- 1985-07-19 US US06/757,104 patent/US4726948A/en not_active Expired - Lifetime
- 1985-07-19 GB GB08518228A patent/GB2162063B/en not_active Expired
- 1985-07-19 DE DE3525902A patent/DE3525902C2/de not_active Expired - Fee Related
- 1985-07-22 FR FR8511163A patent/FR2573982B1/fr not_active Expired
- 1985-07-22 CA CA000487217A patent/CA1260390A/en not_active Expired
- 1985-07-22 CH CH3169/85A patent/CH667775A5/fr not_active IP Right Cessation
- 1985-07-22 IE IE183285A patent/IE58733B1/en not_active IP Right Cessation
- 1985-07-23 NL NL8502110A patent/NL8502110A/nl active Search and Examination
- 1985-07-23 SE SE8503570A patent/SE463069B/sv not_active IP Right Cessation
- 1985-07-24 NO NO852937A patent/NO165473C/no unknown
- 1985-07-24 PT PT80861A patent/PT80861B/pt not_active IP Right Cessation
- 1985-07-24 JP JP60162175A patent/JPS6183131A/ja active Pending
- 1985-07-24 DK DK336285A patent/DK163951C/da not_active IP Right Cessation
- 1985-07-25 NZ NZ212869A patent/NZ212869A/xx unknown
- 1985-07-25 FI FI852905A patent/FI86133C/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU4515585A (en)	1986-01-30
CA1260390A (en)	1989-09-26
PT80861B (pt)	1987-11-30
DE3525902A1 (de)	1986-01-30
FI86133C (fi)	1992-07-27
DK163951C (da)	1992-09-21
GB2162063B (en)	1988-12-21
DK336285D0 (da)	1985-07-24
NZ212869A (en)	1990-09-26
NL8502110A (nl)	1986-02-17
PT80861A (en)	1985-08-01
IT1187697B (it)	1987-12-23
FR2573982B1 (fr)	1988-12-30
FI86133B (fi)	1992-04-15
IT8521651A0 (it)	1985-07-19
DK163951B (da)	1992-04-27
AU582769B2 (en)	1989-04-13
IE58733B1 (en)	1993-11-03
JPS6183131A (ja)	1986-04-26
DK336285A (da)	1986-01-26
BE902943A (fr)	1986-01-20
FR2573982A1 (fr)	1986-06-06
FI852905A0 (fi)	1985-07-25
NO165473B (no)	1990-11-12
DE3525902C2 (de)	1997-04-24
FI852905L (fi)	1986-01-26
NO852937L (no)	1986-01-27
GB8518228D0 (en)	1985-08-29
LU85479A1 (fr)	1986-02-12
IE851832L (en)	1986-01-25
NO165473C (no)	1991-02-20
SE8503570L (sv)	1986-01-26
SE8503570D0 (sv)	1985-07-23
CH667775A5 (fr)	1988-11-15
US4726948A (en)	1988-02-23
GB2162063A (en)	1986-01-29

Legal Events

Date

Code

Title

Description

1995-01-31

NAL

Patent in force

Ref document number: 8503570-7

Format of ref document f/p: F

2004-03-02

NUG

Patent has lapsed

Publication	Publication Date	Title
SE463069B (sv)	1990-10-08	Foerfarande foer framstaellning av livsmedel eller djurfoder innehaallande ett antibakteriellt system, daervid framstaellda produkter samt det antibakteriella systemet innefattande laktoperoxidas och laktoferrin
Wolfson et al.	1993	Antibacterial activity of the lactoperoxidase system: a review
DE2709390C2 (da)	1989-01-12
US5718894A (en)	1998-02-17	Formulation and use of microorganisms in treating livestock
BG60261B2 (en)	1994-03-31	Lon-acting formulation of cefaclor
EP0128610A3 (en)	1987-08-26	Sterilization and stabilization process for food products containing meat and/or analogs
JP3260111B2 (ja)	2002-02-25	鳥類の給餌中止時の体重減少抑制方法及び腸内有害細菌減少方法
US4171379A (en)	1979-10-16	Feed supplement for baby pigs
EP0381700B1 (en)	1995-05-24	The use of a fructooligosaccharid in the manufacture of a bacteriostatic composition for inhibiting the growth of Salmonella and a process for inhibiting the growth of Salmonella in a food animal
US3881003A (en)	1975-04-29	Compositions containing 3-sulfanilamido-4,5-dimethylisoxazole and a trimethoxybenzyl pyrimidine
KR101147630B1 (ko)	2012-05-23	산란계용 사료 첨가제 및 당해 첨가제를 함유하는 사료
US4276286A (en)	1981-06-30	Process for decreasing ammonia concentration in domestic animals or fowls
Friedman et al.	1987	Nutritional value and safety in mice of proteins and their admixtures with carbohydrates and vitamin C after heating
JPS62249931A (ja)	1987-10-30	抗菌性組成物
JPH0499730A (ja)	1992-03-31	褐変防止剤
SELL et al.	1982	Adverse effect of dietary vanadium, contributed by dicalcium phosphate, on albumen quality
US3708578A (en)	1973-01-02	Composition and method for inhibiting the growth of animal pathogens
JPH02191205A (ja)	1990-07-27	生物活性組成物
EP0702898B1 (en)	2000-11-08	A process for the production of alkali-treated powder possessing an immunological activity
DE2451388A1 (de)	1975-05-07	Verfahren zur entgiftung von kleber in nahrungsmitteln
Yannai et al.	1983	Gossypol in cottonseed products: toxicology and inactivation
EP3741222A1 (en)	2020-11-25	Method of activating mixture of lyophilized acidophilic bacteria of milk acid intended for low temperature decontamination of ochratoxin a in food blood
Palm et al.	1968	Pantothenic acid requirement of young swine
JPH0725B2 (ja)	1995-01-11	高温菌の増殖を抑制できる食品
DD291697A5 (de)	1991-07-11	Futtermittelzusatz fuer futter landwirtschaftlicher nutztiere